MOKSHA8

Serial Number 77144411
606

Registration Progress

Application Filed
Mar 30, 2007
Under Examination
Jun 17, 2008
Approved for Publication
Mar 5, 2008
Published for Opposition
Mar 25, 2008
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: MOKSHA8
Previous Owner: Moksha8 Pharmaceuticals, Inc.
Classes: 005

Trademark Image

MOKSHA8

Basic Information

Serial Number
77144411
Filing Date
March 30, 2007
Published for Opposition
March 25, 2008
Abandonment Date
July 18, 2011
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jul 18, 2011
Classes
005

Rights Holder

Moksha8 Pharmaceuticals, Inc.

03
Address
Suite 300
1550 Liberty Ridge Drive
Wayne, PA 19087

Ownership History

Moksha8 Pharmaceuticals, Inc.

Original Applicant
03
San Francisco, CA

Moksha8 Pharmaceuticals, Inc.

Owner at Publication
03
Wayne, PA

Legal Representation

Attorney
Susan D. Berney-Key, John W. Crittenden, Janet L. Cullum, Andrew Hartman, Anne H. Peck, Kent M. Walker, Peter J. Willsey, Todd S. Bontemps, Emily F. Burns, Catherine A. Cayce, Gavin L. Charlston, Einat Sandman Clarke, Christen Dubois, Heather Dunn Navarro, Noel K. Egnatios, Christine K. Hsieh, Brendan J. Hughes, Lisa K. Koenig, Nishan Kottahachchi, Jeffrey T. Norberg, Susan L. Piascik, Alex C. Sears, Steven Tietsworth and Kathleen E. Treiber

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

35 events
Date Code Type Description Documents
Jul 18, 2011 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Jul 18, 2011 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Dec 28, 2010 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 27, 2010 EX5G S SOU EXTENSION 5 GRANTED Loading...
Dec 17, 2010 EXT5 S SOU EXTENSION 5 FILED Loading...
Dec 17, 2010 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 23, 2010 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 22, 2010 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jun 14, 2010 EXT4 S SOU EXTENSION 4 FILED Loading...
Jun 14, 2010 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 27, 2010 EX3G S SOU EXTENSION 3 GRANTED Loading...
Dec 16, 2009 EXT3 S SOU EXTENSION 3 FILED Loading...
Jan 27, 2010 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Dec 16, 2009 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 10, 2009 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jun 9, 2009 EXT2 S SOU EXTENSION 2 FILED Loading...
Jun 9, 2009 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 7, 2009 EX1G S SOU EXTENSION 1 GRANTED Loading...
Dec 17, 2008 EXT1 S SOU EXTENSION 1 FILED Loading...
Jan 7, 2009 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Dec 17, 2008 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 17, 2008 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 25, 2008 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 5, 2008 NPUB O NOTICE OF PUBLICATION Loading...
Feb 16, 2008 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Feb 15, 2008 ALIE A ASSIGNED TO LIE Loading...
Jan 16, 2008 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 10, 2008 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 8, 2008 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 8, 2008 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 13, 2007 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jul 13, 2007 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jul 13, 2007 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jul 13, 2007 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 3, 2007 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the circulatory system, the pulmonary system, the metabolic system, the digestive system, the respiratory system, the musculo-skeletal system, the genitourinary system, the endocrine system, the reproductive system, the lymphatic system; pharmaceutical preparations for the treatment of asthma; pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations for the treatment of osteoporosis and bone diseases; pharmaceutical preparations for the treatment of hormonal disorders; pharmaceutical preparations for use in pregnancy and obstetrics; pharmaceutical preparations for use in gynecological disorders; pharmaceutical preparations for the treatment of kidney disease, for the treatment of liver disease; pharmaceutical preparations for use in dermatology, rheumatology, oncology, dialysis and hematology; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations for use in ophthalmology and ocular disorders; pharmaceutical preparations for use in the treatment of infectious disease, diabetes and gout; pharmaceutical preparations for use in the treatment of erectile dysfunction; pharmaceutical preparations for the treatment of gastroenterological and gastrointestinal disorders; pharmaceuticals preparations, namely, antibiotics, antiviral and antimicrobial preparations, antifungal preparations, anti-cold and allergy preparations, anticoagulants, anti-arthritic preparations; anti-HIV and anti-AIDS preparations, vitamins, minerals and nutritional preparations; psychotropic preparations; antidepressants; anti-hypertension preparations; diet, weight loss and weight control preparations
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005